Microbiome Characterization System for Skin Conditions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for characterizing human microbiomes and providing tailored therapies are limited by inefficiencies in sample processing, genetic analysis, and data processing, making it difficult to accurately diagnose and treat skin-related conditions based on microbiome composition and functional diversity.
Innovation Solution
A system and method that utilize advanced computer technologies, including artificial intelligence and machine learning, to analyze microbiome sequences, generate characterization models, and recommend therapies by processing microbiome data from biological samples, enabling personalized and efficient diagnosis and treatment of skin-related conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current sample processing and genetic analysis techniques are used to characterize microbiomes, then characterization can be performed, but the process is inefficient and inaccurate due to limitations in processing techniques and data handling
Solution Approach 1:
The patent replaces traditional mechanical and manual sample processing techniques with automated computational systems. Machine learning algorithms and computer-based analysis systems process microbiome data, substituting manual genetic analysis with automated bioinformatics pipelines that improve both accuracy and efficiency simultaneously
Solution Approach 2:
The patent transforms raw microbiome data into meaningful characterizations by changing data parameters through computational processing. Machine learning models transform complex genetic sequences into actionable health insights, changing the state of data from raw sequences to interpreted medical information that guides treatment decisions
2Productivity
If traditional methods are used to analyze large amounts of microbiome data, then data can be processed, but resource consumption is high and processing speed is slow
Solution Approach 1:
The patent applies machine learning models that are trained on comprehensive microbiome datasets but then use the trained models for rapid prediction on individual patient samples. The heavy computational work is performed once during model training, and subsequent patient analyses use the pre-trained model for fast, low-resource predictions, achieving high productivity without proportional resource consumption
Solution Approach 2:
The patent performs preliminary computational work by training machine learning models on large microbiome datasets before actual patient diagnosis. This preliminary action creates pre-computed knowledge structures that enable rapid, resource-efficient analysis of individual patient samples, separating the heavy computational burden from routine clinical use
3Manufacturing precision
If personalized therapies are developed based on individual microbiome composition, then treatment accuracy improves, but the complexity of analysis and therapy determination increases
Solution Approach 1:
The patent develops universal machine learning models that can handle multiple aspects of microbiome analysis simultaneously. A single computational system performs composition analysis, functional diversity assessment, and therapy recommendation, reducing overall system complexity while maintaining high personalization accuracy through multi-functional integration
Solution Approach 2:
The patent introduces machine learning algorithms as intermediaries between raw microbiome data and clinical decision-making. These algorithms translate complex microbiome compositions into simplified risk assessments and therapy recommendations, acting as a mediator that reduces the complexity burden on clinicians while preserving personalized treatment accuracy
Data Source
AI summary
Embodiments of a method and system for characterizing a skin-related condition in relation to a user can include one or more of: a handling network operable to collect containers comprising material from a set of users, the handling network comprising a sequencing system operable to determine microorganism sequences from sequencing the material; a microbiome characterization system operable to: determine at least one of microbiome composition data and microbiome functional diversity data based on the microorganism sequences, collect supplementary data associated with the skin-related condition for the set of users, and transform the supplementary data and the at least one of the microbiome composition data and the microbiome functional diversity data into a characterization model; and a therapy system operable to promote a treatment to the user for the skin-related condition based on characterizing the user with the characterization model in relation to the skin-related condition.